Design and evaluation of double coated floating capsules based on gas formation

Main Article Content

Napatporn Boonyanupap
Satit Puttipipatkhachorn
Nattawut Charoenthai
Srisagul Sungthongjeen

Abstract

The purpose of this work was to create double coated floating capsules using gas formation. Theophylline was used as a model drug. Theophylline and hydroxypropyl methylcellulose (HPMC) were physically blended and filled in hard capsules. Then, they were coated with a layer of a gas producing agent (NaHCO3) and a gas- entrapped membrane. The impact of types of gel-forming polymers, and gas-entrapped membrane's coating types and levels on floating characteristics and drug release from the floating capsules was investigated. Optimum formulations could float immediately and maintain buoyancy longer than 8 h. The increased viscosity of the high molecular weight HPMC in the floating capsules resulted in a delayed drug release, compared to the low molecular weight HPMC-containing capsules. The floating capsules coated with EuRS30D released the drug more slowly than those coated with EuRL30D. Due to EuRS30D demonstrated relatively low drug release, EuRL30D appeared to be a promising option for gas-entrapped membranes. Drug release was decreased as the gas-entrapped membrane's coating level was increased, resulting from a thicker film. The floating capsules with good floating abilities and sustained drug release were obtained in this investigation.

Downloads

Download data is not yet available.

Article Details

How to Cite
Boonyanupap, N., Puttipipatkhachorn, S., Charoenthai, N., & Sungthongjeen, S. (2022). Design and evaluation of double coated floating capsules based on gas formation. Science, Engineering and Health Studies, 16, 22050020. https://doi.org/10.14456/sehs.2022.58
Section
Health sciences

References

Amrutkar, P. P., Chaudhari, P. D., and Patil, S. B. (2012). Design and in vitro evaluation of multiparticulate floating drug delivery system of zolpidem tartarate. Colloids and Surfaces B: Biointerfaces, 89, 182-187.

Bauer, K. H. (1998). Coated Pharmaceutical Dosage Forms, Florida: CRC Press.

Bera, H., Gaini, C., Kumar, S., Sarkar, S., Boddupalli, S., and Ippagunta, S. R. (2016). HPMC-based gastroretentive dual working matrices coated with Ca(+2) ion crosslinked alginate-fenugreek gum gel membrane. Materials Science & Engineering C-Materials for Biological Applications, 67, 170-181.

Chen, C., Han, C. H. S., Sweeney, M., and Cowles, V. E. (2013). Pharmacokinetics, efficacy, and tolerability of a once- daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia. Journal of Pharmaceutical Sciences, 102(4), 1155-1164.

Colombo, P., Bettini, R., M´aximo, G., Catellani, P. L., Santi, P., and Peppas, N. A. (1995). Drug diffusion front movement is important in drug release control from swellable matrix tablets. Journal of Pharmaceutical Sciences, 84(8), 991-997.

Escudero, J. J., Ferrero, C., and Jim´enez-Castellanos M. R. (2008). Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: Effect of HPMC of different viscosity grades. International Journal of Pharmaceutics, 351(1-2), 61-73.

Kim, S., Hwang, K. M., Park, Y. S., Nguyen, T. T., and Park, E. S. (2018). Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics. International Journal of Pharmaceutics, 550(1-2), 160-169.

Klausner, E. A., Lavy, E., Friedman, M., and Hoffman, A. (2003). Expandable gastroretentive dosage forms. Journal of Controlled Release, 90(2), 143-162.

Krögel, I., and Bodmeier R. (1999). Floating or pulsatile drug delivery systems based on coated effervescent cores. International Journal of Pharmaceutics, 187(2), 175- 184.

Kumar, R., Islam, T., and Nurunnabi, M. (2022). Mucoadhesive carriers for oral drug delivery. Journal of Controlled Release, 351, 504-559.

Melocchi, A., Uboldi, M., Inverardi, N., Briatico-Vangosa, F., Baldi, F., Pandini, S., Scalet, G., Auricchio, F., Cerea, M., Foppoli, A., Maroni, A., Zema, L., and Gazzaniga, A. (2019). Expandable drug delivery system for gastric retention based on shape memory polymers: Development via 4D printing and extrusion. International Journal of Pharmaceutics, 571, 118700.

Meng, S., Wang, S., and Piao, M. G. (2022). Prescription optimization of gastroretentive furosemide hollow- bioadhesive microspheres via Box-Behnken design: In vitro characterization and in vivo evaluation. Journal of Drug Delivery Science and Technology, 70, 103235.

Moes, A. J. (1993). Gastroretentive dosage forms. Critical ReviewsTM in Therapeutic Drug Carrier Systems, 10, 143- 195.

Munday, D. L. (2003). Film coated pellets containing verapamil hydrochloride: Enhanced dissolution into neutral medium. Drug Development and Industrial Pharmacy, 29(5), 575-583.

Oth, M., Franz, M., Timmermans, J., and Möes, A. (1992). The bilayer floating capsule: A stomach-directed drug delivery system for misoprostol. Pharmaceutical Research, 9(3), 298- 302.

Patil, T., Pawar, A., Korake, S., Patil, R., Pawar, A., and Kamble, R. (2022). Green synthesis of polyacrylamide grafted Neem Gum for gastro retentive floating drug delivery of Ciprofloxacin Hydrochloride: In vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology, 72, 103417.

Rajput, K., Tawade, S., Nangare, S., Shirsath, N., Bari, S., and Zawar, L. (2022). Formulation, optimization, and in-vitro- ex-vivo evaluation of dual-crosslinked zinc pectinate- neem gum-interpenetrating polymer network mediated lansoprazole loaded floating microbeads. International Journal of Biological Macromolecules, 222(A), 915-926.

Rouge, N., Buri, P., and Doelker, E. (1996). Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. International Journal of Pharmaceutics, 136(1-2), 117-139.

Seta, Y., Higuchi, F., Kawahara, Y., Nishimura, K., and Okada, R. (1988). Design and preparation of captopril sustained- release dosage forms and their biopharmaceutical properties. International Journal of Pharmaceutics, 41(3), 245-254.

Sharma, A., Goyal, A. K., and Rath, G. (2018). Development and characterization of gastroretentive high-density pellets lodged with zero valent iron nanoparticles. Journal of Pharmaceutical Sciences, 107(10), 2663-2673.

Singh, B. N., and Kim, K. H. (2000). Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. Journal of Controlled Release, 63(3), 235-259.

Sriamornsak, P., Huanbutta, K., and Sangnim, T. (2022). Recent advances in 3D printing for floating drug delivery platforms. Science, Engineering and Health Studies, 16, 22010001.

Sungthongjeen, S., Paeratakul, O., Limmatvapirat, S., and Puttipipat-khachorn, S. (2006). Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique. International Journal of Pharmaceutics, 324(2), 136-143.

Treesinchai, S., Puttipipatkhachorn, S., Pitaksuteepong, T., and Sungthongjeen, S. (2019). Development of curcumin floating beads with low density materials and solubilizers. Journal of Drug Delivery Science and Technology, 51, 542-551.

Tripathi, P. K., Singh, S., and Jadhav, K. R. (2021). Floating minitablets loaded with captopril encapsulated microparticles. Journal of Drug Delivery Science and Technology, 63, 102445.

Uboldi, M., Melocchi, A., Moutaharrik, S., Palugan, L., Cerea, M., Foppoli, A., Maroni, A., Gazzaniga, A., and Zema, L. (2022). Administration strategies and smart devices for drug release in specific sites of the upper GI tract. Journal of Controlled Release, 348, 537-552.